Pharmaceutical stocks took a sharp hit on Monday following a renewed pledge by former U.S. President Donald Trump to slash prescription drug prices in the country. In a Truth Social post, Trump committed to reducing prices by 59% — a more aggressive figure compared to his earlier range of 30% to 80%, which he promised would take effect “almost immediately.”